Nanomedicine expert Mauro Ferrari to conduct seminar Oct. 21 at UTSA
By Christi Fish
Public Affairs Specialist
(Oct. 20, 2009)--UTSA will host a nanomedicine seminar featuring Mauro Ferrari from 4 to 5 p.m., Wednesday, Oct. 21 in Biotechnology, Sciences and Engineering Building Room 2.102 on the Main Campus. Ferrari will speak on "Three Dimensions of Individualized Nanomedicine." The lecture is free and open to the public.
The seminar is the second of the Seminars in Translational Research (STRECH) monthly series hosted by UTSA and the University of Texas Health Science Center at San Antonio to foster research collaboration between the two institutions.
Ferrari is professor and chair of the Division of Nanomedicine and Biomedical Engineering at the University of Texas Health Science Center at Houston as well as a professor of internal medicine in its Department of Cardiology. Ferrari serves as professor of experimental therapeutics at M.D. Anderson Cancer Center and as professor of bioengineering at Rice University.
At the Oct. 21 lecture, Ferrari will address the fundamental challenges of nanomedicine, including delivering the right bioactive agents at the right place and time and monitoring their effectiveness and any undesired effects as rapidly as possible.
STRECH is a collaborative project between the UT Health Science Center at San Antonio Institute for Integration of Medicine and Science Novel Clinical and Translational Methodologies, UTSA's Research Center in Minority Institutions, and the joint UTSA-UTHSCSA graduate program in biomedical engineering.
The STRECH seminars bring together investigators from basic, clinical and social sciences to highlight the bidirectional and multiple stages of the scientific translation of research discoveries from the laboratory bench to the bedside and, ultimately, the community.
About Mauro Ferrari
Nanomedicine researcher Mauro Ferrari uses semiconductor nanotechnology and mathematical modeling to solve problems in molecular medicine with a focus on applications in oncology and cardiology. He is regarded as a pioneer in the fields of BioMEMS, biomedical nanotechnology and multi-scale mathematics.
Among his many firsts are silicon-based nanochannel technology; multistage particulates for drug delivery; the rational design of nanovectors; and the use of nanotextured chips for the selective enrichment of the plasma peptidome for early detection of pathological states. Recently, Ferrari was featured in Nature's "Straight Talk With Mauro Ferrari."